Kenneth K. Sokoll
Keine laufenden Positionen mehr
Profil
Dr. Kenneth K.
Sokoll is Chief Operating Officer & VP-Clinical Development at PharmaGap, Inc.
Dr. Sokoll was previously employed as Vice President-Vaccine Product Development by United Biomedical, Inc., Gérant by Aventis Pasteur Sa, Gérant by Rhodia SA, Vice President-Drug Development by Liponex, Inc., and Vice President-Drug Development by Milestone Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Toronto and a doctorate degree from The University of Waterloo.
Ehemalige bekannte Positionen von Kenneth K. Sokoll
| Unternehmen | Position | Ende |
|---|---|---|
United Biomedical, Inc.
 United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Corporate Officer/Principal | - |
Solvay France SA
 Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
| Aventis Pasteur Sa | Corporate Officer/Principal | - |
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Geschäftsführer | - |
| Liponex, Inc. | Corporate Officer/Principal | - |
Ausbildung von Kenneth K. Sokoll
| University of Toronto | Undergraduate Degree |
| The University of Waterloo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Liponex, Inc. | Health Technology |
Solvay France SA
Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Process Industries |
| Aventis Pasteur Sa | Health Technology |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
United Biomedical, Inc.
United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Health Technology |
